The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

Nicola Squillace,1 Elena Ricci,2 Barbara Menzaghi,3 Giuseppe Vittorio De Socio,4 Simone Passerini,5 Canio Martinelli,6 Maria Sabrina Mameli,7 Paolo Maggi,8 Katia Falasca,9 Laura Cordier,5 Benedetto Maurizio Celesia,10 Elena Salomoni,11 Antonio Di Biagio,12 Giovanni Francesco Pellicanò,13...

Full description

Bibliographic Details
Main Authors: Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò GF, Bonfanti P
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Drug Design, Development and Therapy
Subjects:
hiv
tdf
taf
liver enzymes
Online Access:https://www.dovepress.com/the-effect-of-switching-from-tenofovir-disoproxil-fumarate-tdf-to-teno-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/the-effect-of-switching-from-tenofovir-disoproxil-fumarate-tdf-to-teno-peer-reviewed-article-DDDT

Similar Items